JPRN-UMIN000014237
Completed
未知
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of afatinib - PK analysis of anticancer agent for lung cancer
aboratoly of Pharmacy Practice and Social Science, Gifu Pharmaceutical University0 sites43 target enrollmentJune 25, 2014
Conditionsadenocarcinoma of the lung
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- adenocarcinoma of the lung
- Sponsor
- aboratoly of Pharmacy Practice and Social Science, Gifu Pharmaceutical University
- Enrollment
- 43
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of sunitinibrenal cell carcinomaJPRN-UMIN000015553Department of Pharmacy, Gifu University Hospital50
Completed
Not Applicable
A study to assess the efficacy, safety, pharmacokinetics, and related polymorphism of medicines for pulmonary arterial hypertension in pediatric patientsPulmonary arterial hypertensionJPRN-UMIN000010355Department of clinical pharmacology and genetics, school of pharmaceutical science, university of Shizuoka graduate school100
Not yet recruiting
Not Applicable
Alternative treatment to treatment nonresponsive leprosyHealth Condition 1: A305- Lepromatous leprosyCTRI/2022/09/045483Prof Nusrat Shafiq
Completed
Phase 2
Active phase study of MD-0901 in pediatric ulcerative colitis.Mildly to moderately active ulcerative colitisJPRN-jRCT2080223746MOCHIDA PHARMACEUTICAL CO., LTD26
Completed
Phase 2
Maintenance phase study of MD-0901 in pediatric ulcerative colitis.lcerative colitis in remissionJPRN-jRCT2080223747MOCHIDA PHARMACEUTICAL CO., LTD26